
FFNTF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for FFNTF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for FFNTF and 80,000+ other tickers.
See exactly how FFNTF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for FFNTF and 80,000+ other tickers.
4Front Ventures Corp. is an American company specializing in the management and operation of licensed cannabis facilities across various U.S. states where such activities are legally permitted. Its operations are bifurcated into two primary divisions: THC Cannabis and Cannabidiol (CBD) Wellness. The firm engages in the cultivation, manufacturing, distribution, and retail of both cannabis and CBD products. As of December 31, 2021, it oversaw six dispensaries, primarily under the MISSION brand, situated in Massachusetts, Illinois, and Michigan. In addition to its direct product offerings…

Toronto, Ontario--(Newsfile Corp. - Le 16 janvier/January 2026) - The subordinate voting shares of 4Front Ventures Corp. will be delisted from the CSE at market close today, January 16, 2026. 4Front Ventures Corp. is currently suspended.

PHOENIX , June 26, 2025 /PRNewswire/ - 4Front Ventures Corp. ("4Front" or the "Company") (CSE: FFNT) (OTC: FFNTF), a vertically integrated cannabis operator, provides an update on the voluntary receivership proceedings involving its U.S. subsidiaries and changes to its Board of Directors. As previously announced, on May 22, 2025, all U.S. subsidiaries of 4Front (the "Subsidiaries") filed for voluntary receivership in aid of liquidation under the laws of the Commonwealth of Massachusetts.

PHOENIX , June 10, 2025 /PRNewswire/ - 4Front Ventures Corp. ("4Front" or the "Company") (CSE: FFNT) (OTC: FFNTF), a vertically integrated cannabis operator, announces that, following its previously announced U.S. receivership petition, it has made an assignment into bankruptcy pursuant to the Canadian Bankruptcy and Insolvency Act (the "Canadian Bankruptcy Proceedings"). B. Riley Farber has been appointed as the trustee in the Canadian Bankruptcy Proceedings.

PHOENIX , May 23, 2025 /PRNewswire/ - 4Front Ventures Corp. ("4Front" or the "Company") (CSE: FFNT; OTCQB: FFNTF), a vertically integrated cannabis operator, announces that all its United States subsidiaries filed for a voluntary receivership in aid of liquidation under the laws of the Commonwealth of Massachusetts on May 22, 2025. The Company anticipates that its subsidiaries will be placed into receivership in the Superior Court for Suffolk County, Business Litigation Division.

PHOENIX , May 8, 2025 /PRNewswire/ - 4Front Ventures Corp. ("4Front" or the "Company") (CSE: FFNT) (OTCQB: FFNTF), a vertically integrated cannabis operator, announces that on May 7, 2025, the Ontario Securities Commission ("OSC") issued a failure-to-file cease trade order (the "Order") against the Company. The OSC determined that the Company had not filed the following periodic disclosure required by the securities legislation of Ontario ("Legislation"): audited annual financial statements for the year ended December 31, 2024; management's discussion and analysis relating to the audited annual financial statements for the year ended December 31, 2024; and certification of the foregoing filings as required by National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings.